» Articles » PMID: 9022089

Differentiation of Glucose Toxicity from Beta Cell Exhaustion During the Evolution of Defective Insulin Gene Expression in the Pancreatic Islet Cell Line, HIT-T15

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1997 Feb 1
PMID 9022089
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic exposure of HIT-T15 cells to supraphysiologic glucose concentration diminishes insulin gene expression and decreased binding of two critical insulin gene transcription factors, STF-1 and RIPE-3b1 activator. To distinguish whether these changes are caused by glucose toxicity or beta cell exhaustion, HIT-T15 cells grown from passage 75 through 99 in media containing 11.1 mM glucose were switched to 0.8 mM glucose at passage 100. They regained binding of STF-1 and RIPE-3b1 activator and had a partial but minimal return of insulin mRNA expression. In a second study, inclusion of somatostatin in the media-containing 11.1 mM glucose inhibited insulin secretion; however, despite this protection against beta cell exhaustion, dramatic decreases in insulin gene expression, STF-1 and RIPE-3b1 binding, and insulin gene promoter activity still occurred. These data indicate that the glucotoxic effects caused by chronic exposure to supraphysiologic concentration of glucose are only minimally reversible and that they are not due simply to beta cell exhaustion. These observations carry with them the clinical implication that Type II diabetic patients who remain hyperglycemic for prolonged periods may have secondary glucose toxic effects on the beta cell that could lead to defective insulin gene expression and worsening of hyperglycemia.

Citing Articles

The involvement of the dysfunctional insulin receptor signaling system in long COVID patients with diabetes and chronic pain and its implications for the clinical management using taVNS.

Li R, Liu W, Liu D, Jin X, Wang S Front Pain Res (Lausanne). 2024; 5:1486851.

PMID: 39654800 PMC: 11625755. DOI: 10.3389/fpain.2024.1486851.


Molecular pathways and nutrigenomic review of insulin resistance development in gestational diabetes mellitus.

Guevara-Ramirez P, Paz-Cruz E, Cadena-Ullauri S, Ruiz-Pozo V, Tamayo-Trujillo R, Felix M Front Nutr. 2023; 10:1228703.

PMID: 37799768 PMC: 10548225. DOI: 10.3389/fnut.2023.1228703.


The Role of Adiponectin during Pregnancy and Gestational Diabetes.

Moyce Gruber B, Dolinsky V Life (Basel). 2023; 13(2).

PMID: 36836658 PMC: 9958871. DOI: 10.3390/life13020301.


Evolution of Nrf2 Gene Expression in HIT-T15 β-Cells During Chronic Oxidative Stress and Glucose Toxicity.

Abebe T, Bogachus L, Vegaraju A, Robertson R J Endocr Soc. 2023; 7(3):bvac178.

PMID: 36632484 PMC: 9825721. DOI: 10.1210/jendso/bvac178.


β-cell dynamics in type 2 diabetes and in dietary and exercise interventions.

Lv C, Sun Y, Zhang Z, Aboelela Z, Qiu X, Meng Z J Mol Cell Biol. 2022; 14(7).

PMID: 35929791 PMC: 9710517. DOI: 10.1093/jmcb/mjac046.


References
1.
Sako Y, Grill V . Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes. 1990; 39(12):1580-3. DOI: 10.2337/diab.39.12.1580. View

2.
Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

3.
Kaiser N, Corcos A, Sarel I, Cerasi E . Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. Endocrinology. 1991; 129(4):2067-76. DOI: 10.1210/endo-129-4-2067. View

4.
Zhang H, Redmon J, Andresen J, Robertson R . Somatostatin and epinephrine decrease insulin messenger ribonucleic acid in HIT cells through a pertussis toxin-sensitive mechanism. Endocrinology. 1991; 129(5):2409-14. DOI: 10.1210/endo-129-5-2409. View

5.
Robertson R, Zhang H, Pyzdrowski K, Walseth T . Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest. 1992; 90(2):320-5. PMC: 443105. DOI: 10.1172/JCI115865. View